These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. IL-1beta, TNF-alpha, TGF-beta, and bFGF expression in bone biopsies before and after parathyroidectomy. Santos FR; Moysés RM; Montenegro FL; Jorgetti V; Noronha IL Kidney Int; 2003 Mar; 63(3):899-907. PubMed ID: 12631070 [TBL] [Abstract][Full Text] [Related]
3. Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Piraino B; Chen T; Cooperstein L; Segre G; Puschett J Clin Nephrol; 1988 Aug; 30(2):57-62. PubMed ID: 3180516 [TBL] [Abstract][Full Text] [Related]
4. Azotaemic renal osteodystrophy: a quantitative study on iliac bone. Ellis HA; Peart KM J Clin Pathol; 1973 Feb; 26(2):83-101. PubMed ID: 4696838 [TBL] [Abstract][Full Text] [Related]
5. Development of renal bone disease. Ferreira A Eur J Clin Invest; 2006 Aug; 36 Suppl 2():2-12. PubMed ID: 16884393 [TBL] [Abstract][Full Text] [Related]
6. [Brown tumors in multiple locations: manifestation of severe renal osteodystrophy. Case report]. Gómez MC; Riquelme P; Sirandoni G; Sapunar J; Princic E; Lee B Rev Med Chil; 2003 Oct; 131(10):1183-7. PubMed ID: 14692310 [TBL] [Abstract][Full Text] [Related]
7. Calcium and phosphorus metabolism in chronic uremia. Fiaschi E; Mioni G; Maschio G; D'Angelo A; Ossi E Nephron; 1975; 14(2):163-80. PubMed ID: 1093055 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow immunoscintigraphy (BMIS): a new and important tool for the assessment of marrow fibrosis in renal osteodystrophy? Kim CD; Kim SH; Kim YL; Cho DK; Lee JT Adv Perit Dial; 1998; 14():183-7. PubMed ID: 10649720 [TBL] [Abstract][Full Text] [Related]
14. Current concepts and management strategies in chronic kidney disease-mineral and bone disorder. Chauhan V; Kelepouris E; Chauhan N; Vaid M South Med J; 2012 Sep; 105(9):479-85. PubMed ID: 22948328 [TBL] [Abstract][Full Text] [Related]
15. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings. Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018 [TBL] [Abstract][Full Text] [Related]
16. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697 [TBL] [Abstract][Full Text] [Related]
17. Uremic toxin and bone metabolism. Iwasaki Y; Yamato H; Nii-Kono T; Fujieda A; Uchida M; Hosokawa A; Motojima M; Fukagawa M J Bone Miner Metab; 2006; 24(2):172-5. PubMed ID: 16502128 [TBL] [Abstract][Full Text] [Related]
18. Osteitis fibrosa cystica, coeliac disease and Turner syndrome. A case report. Sleiman I; Godi D; Villanacci V; Pelizzari G; Balestrieri GP Dig Liver Dis; 2004 Jul; 36(7):486-8. PubMed ID: 15285529 [TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of uremic osteodystrophy. Agus ZS; Goldberg M Radiol Clin North Am; 1972 Dec; 10(3):545-56. PubMed ID: 4566892 [No Abstract] [Full Text] [Related]
20. Thoracic Deformity and Acro-Osteolysis in Severe Renal Osteodystrophy. Govindu R; Ammar H Mayo Clin Proc; 2019 Nov; 94(11):2358-2359. PubMed ID: 31685157 [No Abstract] [Full Text] [Related] [Next] [New Search]